Purchase Order 75F40123P00421
Award Date
9/23/23
Potential Completion Date
9/25/28
Potential Value
$125K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a service contract to provide Oxford Nanopore GridION instruments. The contract has a total ceiling value of $50,000.00 and a completion date of February 5, 2023. The contract is not associated with any set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
This federal contract award, valued at $111,255.00, was made by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the provision of one (1) long-read sequencing instrument and one (1) automated library prep instrument. The contract is a firm-fixed-price purchase order with a total small business set-aside designation. It has an ultimate completion date of March 7, 2028. Oxford Nanopore Technologies Inc....
This federal contract award is for the purchase of specific supplies and reagents for an Oxford Nanopore GridION instrument, awarded to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $29,162.00, is a firm fixed-price purchase order placed by the Food and Drug Administration (FDA), a civilian government agency. The award is not associated with a set-aside program and has an ultimate completion date of March 29, 2024. Oxford Nanopore...
Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...
The U.S. Food and Drug Administration (FDA) awarded a $295,137 firm-fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the lease of an Oxford Nanopore PromethION 2 Solo long-read sequencing instrument and the purchase of related consumables. This contract supports the FDA's research on the safety of gene editing technologies in food and drug producing animals, as well as multiple studies by the Division of Emerging...
This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
The Department of Health and Human Services Food and Drug Administration awarded a $116,289.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, to procure a long-read DNA sequencing instrument and associated automated library preparation instrument. The contract has no set-aside designation. The requirement was originally solicited through a competitive process, with Oxford Nanopore securing the award on September 16, 2021. Oxford...
This is a $75,165.00 firm fixed-price purchase order awarded by the U.S. Department of Agriculture's Southeast Area to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a GridION X5 Starter Pack, which includes next-generation genomic sequencing equipment, consumables, and associated services. Oxford Nanopore has secured numerous prime federal contract awards from agencies like the National Institutes of Health, Centers for Disease...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...